Age, Biography and Wiki

John L. Wallace was born on 25 September, 1956 in Toronto, Ontario, Canada, is a John L. Wallace is medical scientist medical scientist. Discover John L. Wallace's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 67 years old?

Popular As N/A
Occupation N/A
Age 67 years old
Zodiac Sign Libra
Born 25 September, 1956
Birthday 25 September
Birthplace Toronto, Ontario, Canada
Nationality Toronto, Ontario

We recommend you to check the complete list of Famous People born on 25 September. He is a member of famous with the age 67 years old group.

John L. Wallace Height, Weight & Measurements

At 67 years old, John L. Wallace height not available right now. We will update John L. Wallace's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

John L. Wallace Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is John L. Wallace worth at the age of 67 years old? John L. Wallace’s income source is mostly from being a successful . He is from Toronto, Ontario. We have estimated John L. Wallace's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

John L. Wallace Social Network

Instagram
Linkedin
Twitter John L. Wallace Twitter
Facebook John L. Wallace Facebook
Wikipedia John L. Wallace Wikipedia
Imdb

Timeline

1956

John L. Wallace (born September 25, 1956) is a medical scientist and was the founder of the Inflammation Research Network at The University of Calgary and inaugural director of the Farncombe Institute at McMaster University.

1972

Since its inauguration in 1972, the Medal had been awarded twelve times; six of the recipients are Nobel Laureates.

1986

From 1986 to 1989, he was an assistant professor at Queen's University.

1989

From 1989 to 2009, Wallace was a professor of Pharmacology and Therapeutics at the University of Calgary, where he held the Canada Research Chair in Inflammation.

In 1989, he joined the University of Calgary, where he founded the Inflammation Research Network and held the Crohn's and Colitis Foundation of Canada Chair in Intestinal Disease Research.

1996

Wallace co-founded NicOx in 1996, creating the first pharmaceutical company to commercialize gaseous mediator technology.

Dr Wallace was chair of NicOx's Scientific Advisory Board from 1996 to 2003, which included Nobel Laureates Bengt Samuelsson and Louis Ignarro.

This board oversaw the development of nitric oxide-releasing NSAIDs.

He is also the founder of Antibe Therapeutics, which is developing a gaseous mediator drug development platform based on hydrogen sulfide.

2005

In 2005, he acted as an invited expert for the US Food and Drug Administration's review of COX-2 inhibitors such as Vioxx.

Wallace graduated from Queen's University with his BSc and MSc and received his PhD from the University of Toronto.

He completed his post-doctoral studies under Dr. Brendan Whittle, Sir John Vane and Sir Salvador Moncada at Wellcome Research Laboratories in the UK.

2008

Wallace received an MBA from the University of Birmingham (UK) in 2008.

2009

Wallace is also the 2009 recipient of the Premier's Summit Award in Innovation, Canada's largest value research award (C$5 million) aimed at supporting the work of an individual scientist.

He is a fellow of the Royal Society of Canada, a member of the Brazilian Academy of Sciences, a fellow of the British Pharmacological Society, and a fellow and former president of the Canadian Association of Gastroenterology.

Wallace is an adjunct professor in the Faculty of Medicine at the University of Calgary, the Department of Pharmacology and Toxicology at the University of Toronto, and in the University Camilo Castelo Branco in São Paulo, Brazil.

He is Chief Scientific Officer of Antibe Therapeutics Inc., which he founded.

Antibe Therapeutics is based in Toronto, Ontario, Canada, and trades on the Toronto Stock Exchange (TSX:ATE).

John L. Wallace is a citizen of Canada, The Republic of Ireland and the United Kingdom.

Wallace's current research focuses on the mechanisms of internal injury induced by non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory drugs.

In parallel, Wallace has been investigating the factors that regulate and promote healing of ulcers.

He is also researching the causes of inflammatory bowel disease (Crohn's disease and ulcerative colitis).

Wallace's career has centred on the use of gaseous mediators to treat inflammation, particularly intestinal injury and dysfunction.

Wallace has published more than 500 peer-reviewed papers and is among the top 0.5 percent of biomedical scientists worldwide in citations (> 42,000), with a current Hirsch index of 110.

2013

In November 2013, he became the tenth recipient of the Heymans Foundation Memorial Medal.

2014

In 2014, Wallace co-founded the Inflammation Research Network of Canada.